Assignee
CADILA HEALTHCARE LTD
IN·81 granted patents·96 pending applications·254 citations·filing 2001–2022
Top patents by PatentIndex Score
177 records- 0193US11433050B2Treatment for primary biliary cholangitisCADILA HEALTHCARE LTD·Filed 2021·Granted Sep 6, 2022·3 cites·10 claims
- 0293US9249134B2Process for preparation of amorphous form of dasatinibCADILA HEALTHCARE LTD·Filed 2014·Granted Feb 2, 2016·30 cites·14 claims
- 0392US7323491B2Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicineCADILA HEALTHCARE LTD·Filed 2004·Granted Jan 29, 2008·36 cites·7 claims
- 0491US6987123B2Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicineCADILA HEALTHCARE LTD·Filed 2001·Granted Jan 17, 2006·31 cites·21 claims
- 0588US11110073B2Storage stable aqueous injectable solution comprising diclofenacCADILA HEALTHCARE LTD·Filed 2018·Granted Sep 7, 2021·6 cites·19 claims
- 0688US7671207B2Process to prepare pioglitazone via several novel intermediatesCADILA HEALTHCARE LTD·Filed 2007·Granted Mar 2, 2010·4 cites·4 claims
- 0787US9845303B2Process for the preparation of dapagliflozinCADILA HEALTHCARE LTD·Filed 2016·Granted Dec 19, 2017·7 cites·15 claims
- 0886US9708365B2Purification process for monoclonal antibodiesCADILA HEALTHCARE LTD·Filed 2014·Granted Jul 18, 2017·12 cites·34 claims
- 0985US9814697B2Composition for nonalcoholic fatty liver disease (NAFLD)CADILA HEALTHCARE LTD·Filed 2016·Granted Nov 14, 2017·10 cites·6 claims
- 1084US9783495B2Treatment for lipodystrophyCADILA HEALTHCARE LTD·Filed 2016·Granted Oct 10, 2017·6 cites·8 claims
- 1184US9598418B2Substituted phthalazin-1 (2H)-one derivatives as selective inhibitors of poly (ADP-ribose) polymerase-1CADILA HEALTHCARE LTD·Filed 2013·Granted Mar 21, 2017·11 cites·15 claims
- 1284US7863300B2Process to prepare pioglitazone via several novel intermediatesCADILA HEALTHCARE LTD·Filed 2008·Granted Jan 4, 2011·4 cites·5 claims
- 1383US9656954B2Synergistic compositionsCADILA HEALTHCARE LTD·Filed 2014·Granted May 23, 2017·8 cites·14 claims
- 1482US10550150B2Short-chain peptides as Kappa (κ) opioid receptors (KOR) agonistCADILA HEALTHCARE LTD·Filed 2016·Granted Feb 4, 2020·5 cites·8 claims
- 1582US9682045B2Stable pharmaceutical compositions of thyroid hormone drugCADILA HEALTHCARE LTD·Filed 2015·Granted Jun 20, 2017·5 cites·14 claims
- 1682US9610277B2Formula comprising a hypolipidemic agentCADILA HEALTHCARE LTD·Filed 2014·Granted Apr 4, 2017·9 cites·23 claims
- 1782US9394300B2Quinolone derivativesCADILA HEALTHCARE LTD·Filed 2013·Granted Jul 19, 2016·7 cites·10 claims
- 1879US9611225B2Process for preparation of androgen receptor antagonistCADILA HEALTHCARE LTD·Filed 2015·Granted Apr 4, 2017·3 cites·6 claims
- 1979US9351957B2Amorphous form of apremilastCADILA HEALTHCARE LTD·Filed 2015·Granted May 31, 2016·4 cites·20 claims
- 2079US7872019B2Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfateCADILA HEALTHCARE LTD·Filed 2003·Granted Jan 18, 2011·10 cites·33 claims
- 2177US10385017B2Pyrrole compound, compositions and process for preparation thereofCADILA HEALTHCARE LTD·Filed 2016·Granted Aug 20, 2019·5 cites·20 claims
- 2277US10098868B2Formula comprising a hypolipidemic agentCADILA HEALTHCARE LTD·Filed 2017·Granted Oct 16, 2018·3 cites·23 claims
- 2375US10435363B2Process for preparation of pyrroles having hypolipidemic hypocholesteremic activitiesCADILA HEALTHCARE LTD·Filed 2016·Granted Oct 8, 2019·3 cites·6 claims
- 2475US10093728B2Pharmaceutical formulations of TNF-alpha antibodiesCADILA HEALTHCARE LTD·Filed 2013·Granted Oct 9, 2018·4 cites·11 claims
- 2575US9988398B2Crystalline form of rifaximin and process for its preparationCADILA HEALTHCARE LTD·Filed 2017·Granted Jun 5, 2018·2 cites·10 claims
- 2674US11236045B2Substituted sulfoximine compoundsCADILA HEALTHCARE LTD·Filed 2018·Granted Feb 1, 2022·1 cites·7 claims
- 2774US9840509B2Heterocyclic compoundsCADILA HEALTHCARE LTD·Filed 2015·Granted Dec 12, 2017·3 cites·6 claims
- 2874US8829186B2Method for preparation of pitavastatin and pharmaceutical acceptable salts thereofCADILA HEALTHCARE LTD·Filed 2012·Granted Sep 9, 2014·2 cites·30 claims
- 2974US7465801B2Process to prepare pioglitazone via several novel intermediatesCADILA HEALTHCARE LTD·Filed 2003·Granted Dec 16, 2008·4 cites·8 claims
- 3072US9382209B2Polymorphic forms of ivabradine hydrochlorideCADILA HEALTHCARE LTD·Filed 2015·Granted Jul 5, 2016·1 cites·13 claims
- 3172US9120755B2Polymorphic forms of ivabradine hydrochlorideCADILA HEALTHCARE LTD·Filed 2012·Granted Sep 1, 2015·3 cites·11 claims
- 3272US2021128525A1Treatment for primary biliary cholangitisCADILA HEALTHCARE LTD·Filed 2021·Application pending·0 cites
- 3371US9650344B2Polymorphic forms of ivabradine hydrochlorideCADILA HEALTHCARE LTD·Filed 2016·Granted May 16, 2017·1 cites·10 claims
- 3470US10899713B2Process for the preparation of quinolone based compoundsCADILA HEALTHCARE LTD·Filed 2019·Granted Jan 26, 2021·1 cites·55 claims
- 3570US10246470B2Heterocyclic compoundsCADILA HEALTHCARE LTD·Filed 2018·Granted Apr 2, 2019·1 cites·1 claims
- 3670US8030345B2Tricyclic pyrazole derivatives as cannabinoid receptor modulatorsCADILA HEALTHCARE LTD·Filed 2005·Granted Oct 4, 2011·1 cites·12 claims
- 3769US9789123B2Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasisCADILA HEALTHCARE LTD·Filed 2015·Granted Oct 17, 2017·1 cites·11 claims
- 3869US2021085644A1Treatment for primary biliary cholangitisCADILA HEALTHCARE LTD·Filed 2020·Application pending·0 cites
- 3967US2018243263A1Treatment for primary biliary cholangitisCADILA HEALTHCARE LTD·Filed 2017·Application pending·0 cites
- 4066US2023047111A1Pharmaceutical formulations of tnf-alpha antibodiesCADILA HEALTHCARE LTD·Filed 2022·Application pending·0 cites
- 4165US8383581B2Short-chain peptides as parathyroid hormone (PTH) receptor agonistCADILA HEALTHCARE LTD·Filed 2010·Granted Feb 26, 2013·1 cites·20 claims
- 4265US7923220B2Process for preparing high levels of interferon betaCADILA HEALTHCARE LTD·Filed 2005·Granted Apr 12, 2011·2 cites·13 claims
- 4364US7732608B2Salts of clopidogrel and process for preparationCADILA HEALTHCARE LTD·Filed 2004·Granted Jun 8, 2010·1 cites·9 claims
- 4463US10358440B2Process for the preparation of brexpiprazole and intermediates thereofCADILA HEALTHCARE LTD·Filed 2019·Granted Jul 23, 2019·0 cites·8 claims
- 4563US9951009B2Polymorphic form of pyrrole derivative and intermediate thereofCADILA HEALTHCARE LTD·Filed 2014·Granted Apr 24, 2018·0 cites·4 claims
- 4663US9242926B2Processes for the preparation of lacosamide and intermediates thereofCADILA HEALTHCARE LTD·Filed 2014·Granted Jan 26, 2016·0 cites·5 claims
- 4761US9840469B2Polymorphic forms of ivabradine hydrochlorideCADILA HEALTHCARE LTD·Filed 2017·Granted Dec 12, 2017·0 cites·16 claims
- 4861US7348342B2Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicineCADILA HEALTHCARE LTD·Filed 2003·Granted Mar 25, 2008·2 cites·19 claims
- 4960US7994322B2Processes for the preparation of different forms of (S)-(+)-clopidogrel besylateCADILA HEALTHCARE LTD·Filed 2006·Granted Aug 9, 2011·0 cites·2 claims
- 5059US11254675B2Process for preparation of grapiprantCADILA HEALTHCARE LTD·Filed 2020·Granted Feb 22, 2022·0 cites·4 claims
Showing the top 50 of 177 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CADILA HEALTHCARE LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →